A detailed history of Probity Advisors, Inc. transactions in Zimmer Biomet Holdings, Inc. stock. As of the latest transaction made, Probity Advisors, Inc. holds 3,534 shares of ZBH stock, worth $376,653. This represents 0.1% of its overall portfolio holdings.

Number of Shares
3,534
Previous 3,348 5.56%
Holding current value
$376,653
Previous $407,000 14.5%
% of portfolio
0.1%
Previous 0.09%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

BUY
$119.98 - $132.61 $22,316 - $24,665
186 Added 5.56%
3,534 $466,000
Q4 2023

Feb 12, 2024

SELL
$102.72 - $121.7 $31,021 - $36,753
-302 Reduced 8.27%
3,348 $407,000
Q3 2023

Nov 14, 2023

SELL
$110.76 - $143.18 $9,746 - $12,599
-88 Reduced 2.35%
3,650 $409,000
Q2 2023

Aug 10, 2023

SELL
$126.43 - $145.6 $14,792 - $17,035
-117 Reduced 3.04%
3,738 $544,000
Q4 2022

Feb 14, 2023

SELL
$104.7 - $128.4 $16,437 - $20,158
-157 Reduced 3.91%
3,855 $491,000
Q3 2022

Nov 14, 2022

SELL
$101.65 - $119.27 $23,277 - $27,312
-229 Reduced 5.4%
4,012 $419,000
Q2 2022

Aug 12, 2022

SELL
$102.23 - $133.85 $2,760 - $3,613
-27 Reduced 0.63%
4,241 $446,000
Q1 2022

May 10, 2022

SELL
$108.42 - $129.58 $2,168 - $2,591
-20 Reduced 0.47%
4,268 $546,000
Q4 2021

Feb 10, 2022

SELL
$115.43 - $146.63 $9,696 - $12,316
-84 Reduced 1.92%
4,288 $545,000
Q3 2021

Oct 08, 2021

BUY
$136.35 - $158.76 $6,272 - $7,302
46 Added 1.06%
4,372 $640,000
Q2 2021

Aug 06, 2021

SELL
$152.95 - $173.41 $1,682 - $1,907
-11 Reduced 0.25%
4,326 $696,000
Q1 2021

Apr 28, 2021

SELL
$148.16 - $159.71 $31,854 - $34,337
-215 Reduced 4.72%
4,337 $694,000
Q3 2020

Nov 09, 2020

BUY
$113.59 - $141.68 $20,559 - $25,644
181 Added 4.14%
4,552 $620,000
Q2 2020

Aug 03, 2020

SELL
$87.02 - $133.4 $386,803 - $592,963
-4,445 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$78.28 - $155.73 $1,722 - $3,426
-22 Reduced 0.49%
4,445 $449,000
Q4 2019

Feb 13, 2020

SELL
$127.4 - $146.83 $11,466 - $13,214
-90 Reduced 1.97%
4,467 $669,000
Q3 2019

Nov 14, 2019

BUY
$113.33 - $138.46 $2,266 - $2,769
20 Added 0.44%
4,557 $626,000
Q2 2019

Aug 08, 2019

SELL
$108.87 - $125.09 $10,233 - $11,758
-94 Reduced 2.03%
4,537 $534,000
Q1 2019

Apr 29, 2019

BUY
$97.5 - $125.79 $6,435 - $8,302
66 Added 1.45%
4,631 $591,000
Q4 2018

Feb 12, 2019

SELL
$94.4 - $126.76 $35,683 - $47,915
-378 Reduced 7.65%
4,565 $473,000
Q3 2018

Nov 14, 2018

SELL
$108.41 - $127.64 $542 - $638
-5 Reduced 0.1%
4,943 $650,000
Q2 2018

Aug 13, 2018

BUY
$102.12 - $114.04 $10,926 - $12,202
107 Added 2.21%
4,948 $551,000
Q1 2018

Apr 16, 2018

BUY
$104.31 - $124.46 $13,247 - $15,806
127 Added 2.69%
4,841 $528,000
Q4 2017

Feb 09, 2018

SELL
$105.55 - $120.83 $28,920 - $33,107
-274 Reduced 5.49%
4,714 $569,000
Q3 2017

Oct 27, 2017

BUY
$106.92 - $117.79 $533,316 - $587,536
4,988
4,988 $584,000

Others Institutions Holding ZBH

About ZIMMER BIOMET HOLDINGS, INC.


  • Ticker ZBH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 209,820,000
  • Market Cap $22.4B
  • Description
  • Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...
More about ZBH
Track This Portfolio

Track Probity Advisors, Inc. Portfolio

Follow Probity Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Probity Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Probity Advisors, Inc. with notifications on news.